Načítá se...
CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection
BACKGROUND: The gene for chromodomain helicase/ATPase DNA binding protein 1-like (CHD1L) was recently identified as a target oncogene within the 1q21 amplicon, which occurs in 46% to 86% of primary hepatocellular carcinoma (HCC) cases. However, the prognostic significance of CHD1L in HCC remains unc...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Korean Society of Pathologists and The Korean Society for Cytopathology
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3589617/ https://ncbi.nlm.nih.gov/pubmed/23482400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/KoreanJPathol.2013.47.1.9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|